Verdence Capital Advisors LLC
Position in A — Agilent Technologies, Inc.
CIK 1719305
HUNT VALLEY, MD
Position in A
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$301,258
+$82,759 QoQ
Shares Held
2,268
+18.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#740
of 1,112 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Verdence Capital Advisors LLC holds $16,392,769 across 8 Diagnostics & Research names. A ranks #6 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
15,246 | $7,643,734 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
28,242 | $5,456,919 | |
| 3 | DHR |
Danaher Corp /De/
|
8,284 | $1,577,936 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
595 | $760,118 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
653 | $345,822 | |
| 6 | A |
Agilent Technologies, Inc.
This page
|
2,268 | $301,258 | |
| 7 | DGX |
Quest Diagnostics Inc
|
1,131 | $239,715 | |
| 8 | ADPT |
Adaptive Biotechnologies Corp
|
3,136 | $67,267 |
All Filings in A
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $301,258 | 2,268 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $218,499 | 1,917 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $249,144 | 1,831 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $235,008 | 1,831 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $214,542 | 1,818 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $202,609 | 1,732 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $233,617 | 1,739 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $259,988 | 1,751 | Shares | Sole | 2024-11-01 | |
| No filing history on record for this holder in this stock. | ||||||